Zoom, Roku, Novavax and more

A trader who works after the Nasdaq opening bell ceremony on April 18, 2019 in New York City.

Kena Betancur | Getty Images

Check out the companies making headlines after the bell on Monday:

Zoom Video – The shares of the videocommunication company soared 8.5% due to better-than-expected fiscal results for the fourth quarter. Zoom earned $ 1.22 per share on revenue of $ 882 million. Analysts polled by Refinitiv had expected a profit of 79 cents per share on revenue of $ 812 million. This revenue number represents an increase of 369% on a year-over-year basis. Zoom also expects revenue to grow 175% in the first fiscal quarter and 42% in the entire fiscal year.

Roku – Roku’s shares jumped 2.8% with news that the company is about to acquire Nielsen’s video advertising business. “Combining Nielsen’s AVA technology with Roku’s innovative advertising technology and scale will allow us to deliver the benefits of streaming TV advertising to traditional TV,” said Louqman Parampath, vice president of product management at Roku, in a communicated.

Novavax – The vaccine developer’s stock fell 4.2% after the company reported weaker-than-expected results in the fourth quarter. Novavax lost $ 2.70 per share and revenue of $ 279.7 million. Analysts surveyed by Refinitv had expected a loss per share of $ 1.49 on revenue of $ 304.9 million. CEO Stanley Erck told CNBC that the company expects government clearance for its Covid-19 vaccine as early as May.

Inovio Pharmaceuticals – Inovio’s shares fell more than 6% after the company released its latest quarterly figures. The company lost 14 cents per share, while analysts polled by FactSet had expected a loss of 22 cents per share. In addition, Inovio released the results of the Phase 3 trial of a drug intended for the treatment of HPV.

.Source